4th Quarter - Report

PKD FOUNDATION for PKD FOUNDATION

Firm
Client
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

NIH report language request - FY 2010 Labor-HHS-Education Appropriations Act PKD listed in the Peer Reviewed Medical Reserach Program (PRMRP) in the FY 2010 Defense Appropriations Act

LobbyistCovered position, as disclosed
KIMBERLY CANTOR New —
DAN E LARSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Act (HR 1458/S. 565)

LobbyistCovered position, as disclosed
KIMBERLY CANTOR New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 565 (111th), H.R. 1458 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.